The Food and Drug Administration (FDA) said on Friday that it was “expediting” its efforts to develop rules for CBD and plans to issue a report on the department’s progress by early fall.
FDA Acting Chief Information Officer Amy Abernethy tweeted that “FDA is expediting its work to address the many questions about cannabidiol (CBD),” describing it as “an important national issue with public health impact, & an important topic for American hemp farmers and many other stakeholders.”
“We are enthusiastic about research into the therapeutic benefits of CBD products but also need to balance safety,” she said.
Click here to read the complete article
Kyle Jaeger ~ MarijuanaMoment.net ~
